OFM

Omega Fund Management Portfolio holdings

AUM $154M
This Quarter Return
-22.2%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$169M
AUM Growth
+$169M
Cap. Flow
+$69M
Cap. Flow %
40.74%
Top 10 Hldgs %
97.9%
Holding
14
New
2
Increased
–
Reduced
–
Closed
1

Top Buys

1
KMTS
Kestra Medical Technologies, Ltd. Common Stock
KMTS
$44.8M
2
BBNX
Beta Bionics, Inc. Common Stock
BBNX
$24.3M

Top Sells

1
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$57.8K

Sector Composition

1 Healthcare 99.89%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KMTS
1
Kestra Medical Technologies, Ltd. Common Stock
KMTS
$829M
$44.8M 26.41% +1,795,893 New +$44.8M
BCAX
2
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
$28.7M 16.95% 2,204,650 – –
BBNX
3
Beta Bionics, Inc. Common Stock
BBNX
$819M
$24.3M 14.36% +1,988,287 New +$24.3M
NUVB icon
4
Nuvation Bio
NUVB
$1.02B
$23M 13.58% 13,072,340 – –
REPL icon
5
Replimune Group
REPL
$422M
$19.3M 11.36% 1,975,203 – –
UPB
6
Upstream Bio, Inc. Common Stock
UPB
$923M
$12.5M 7.35% 2,036,293 – –
LXEO icon
7
Lexeo Therapeutics
LXEO
$259M
$4.11M 2.43% 1,184,636 – –
ALMS
8
Alumis Inc. Common Stock
ALMS
$479M
$4.01M 2.37% 653,223 – –
IMA
9
ImageneBio, Inc. Common Stock
IMA
$150M
$2.88M 1.7% 2,249,123 – –
ENGN icon
10
enGene Holdings
ENGN
$236M
$2.36M 1.39% 526,357 – –
IMUX icon
11
Immunic
IMUX
$80.9M
$1.95M 1.15% 1,788,160 – –
SANA icon
12
Sana Biotechnology
SANA
$777M
$1.42M 0.84% 843,750 – –
ENGNW icon
13
enGene Holdings Inc. Warrants
ENGNW
$7.08M
$193K 0.11% 321,502 – –
SYRS
14
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
– – -251,270 Closed -$57.8K